Fresenius Medical Care AG & Co. KGaA (FME) Given a €93.00 Price Target by Morgan Stanley Analysts

Morgan Stanley set a €93.00 ($108.14) target price on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note published on Wednesday. The firm currently has a neutral rating on the stock.

Several other brokerages have also recently issued reports on FME. HSBC set a €107.00 ($124.42) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Tuesday, August 28th. Berenberg Bank set a €100.80 ($117.21) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Wednesday, July 25th. Independent Research set a €77.00 ($89.53) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a research note on Wednesday, October 31st. Barclays set a €86.00 ($100.00) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a research note on Monday, July 16th. Finally, Goldman Sachs Group set a €98.00 ($113.95) price objective on Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Friday, August 24th. Eight research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. The stock currently has a consensus rating of Buy and an average target price of €90.14 ($104.82).

Shares of FME opened at €70.82 ($82.35) on Wednesday. Fresenius Medical Care AG & Co. KGaA has a 12-month low of €75.53 ($87.83) and a 12-month high of €93.82 ($109.09).

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the U.S.

Read More: Treasury Bonds

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply